204 related articles for article (PubMed ID: 872113)
41. Immunogenicity of N-[-4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer.
Soloway MS; Martino C; Hyatt C; Marrone JC
Natl Cancer Inst Monogr; 1978 Dec; (49):293-300. PubMed ID: 748783
[TBL] [Abstract][Full Text] [Related]
42. Correlations between cell surface protease activities and abnormalities of occludens junctions in rat bladder carcinoma in vitro.
Pauli BU; Weinstein RS
Cancer Res; 1982 Jun; 42(6):2289-97. PubMed ID: 7042081
[TBL] [Abstract][Full Text] [Related]
43. Effect of phenobarbital on the carcinogenesis of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
Wang CY; Garner CD; Hirose M
Cancer Lett; 1983 Jul; 19(3):305-10. PubMed ID: 6883313
[TBL] [Abstract][Full Text] [Related]
44. [Experimental replication of bladder tumors. Morphologic features of early stages of their development].
Anichkov NM
Vestn Akad Med Nauk SSSR; 1979; (9):85-90. PubMed ID: 386636
[No Abstract] [Full Text] [Related]
45. Enhancement of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced carcinogenesis by urinary tract infection in rats.
Johansson SL; Anderström C; von Schultz L; Larsson P
Cancer Res; 1987 Jan; 47(2):559-62. PubMed ID: 3539325
[TBL] [Abstract][Full Text] [Related]
46. Urinary bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in female Swiss mice.
Ertürk E; Cohen SM; Bryan GT
Cancer Res; 1970 May; 30(5):1309-11. PubMed ID: 5426933
[No Abstract] [Full Text] [Related]
47. Effect of dose on the induction of urothelial proliferation by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and its relationship to bladder carcinogenesis in the rat.
Hasegawa R; Cohen SM; St John M; Cano M; Ellwein LB
Carcinogenesis; 1986 Apr; 7(4):633-6. PubMed ID: 3698195
[TBL] [Abstract][Full Text] [Related]
48. The effects of topical instillation of adriamycin in bladder tumors of rats fed with FANFT.
Pontes JE; Izbicki R; Silberberg B; Baker L; Pierce JM
Invest Urol; 1978 Jan; 15(4):278-9. PubMed ID: 627470
[TBL] [Abstract][Full Text] [Related]
49. Some ultrastructural aspects of experimental and human carcinoma of the bladder.
Koss LG
Cancer Res; 1977 Aug; 37(8 Pt 2):2824-35. PubMed ID: 326393
[No Abstract] [Full Text] [Related]
50. In vitro characterization of four N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide (FANFT) induced mouse bladder tumors.
Mickey DD; Mickey GH; Murphy WM; Niell HB; Soloway MS
J Urol; 1982 Jun; 127(6):1233-7. PubMed ID: 7087044
[TBL] [Abstract][Full Text] [Related]
51. Effects of urine and continued exposure to carcinogen on progression of early neoplastic urinary bladder lesions.
Rowland RG; Henneberry MO; Oyasu R; Grayhack JT
Cancer Res; 1980 Dec; 40(12):4524-7. PubMed ID: 7438086
[TBL] [Abstract][Full Text] [Related]
52. Production of urinary tract tumors by co-administration of uracil and N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in F344 rats.
Wang CY; Kamiryo Y; Hayashida S; Croft WA
Cancer Lett; 1987 Mar; 34(3):249-55. PubMed ID: 3828979
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of the effects of cotinine and nicotine-N'-oxides on the development of tumors in rats initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
LaVoie EJ; Shigematsu A; Rivenson A; Mu B; Hoffmann D
J Natl Cancer Inst; 1985 Dec; 75(6):1075-81. PubMed ID: 3865011
[TBL] [Abstract][Full Text] [Related]
54. The production of carcinoma of the urinary bladder in rats by feeding N-[3-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Ertürk E; Price JM; Morris JE; Cohen S; Leith RS; Von Esch AM; Crovetti AJ
Cancer Res; 1967 Nov; 27(11):1998-2002. PubMed ID: 6073497
[No Abstract] [Full Text] [Related]
55. Comparative urinary and gallbladder carcinogenicity of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide and N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide in the dog.
Ertürk E; Atassi SA; Yoshida O; Cohen SM; Price JM; Bryan GT
J Natl Cancer Inst; 1970 Sep; 45(3):535-42. PubMed ID: 4331642
[No Abstract] [Full Text] [Related]
56. Effect of L-tryptophan excess and vitamin B6 deficiency on rat urinary bladder cancer promotion.
Birt DF; Julius AD; Hasegawa R; St John M; Cohen SM
Cancer Res; 1987 Mar; 47(5):1244-50. PubMed ID: 3815336
[TBL] [Abstract][Full Text] [Related]
57. Enhanced macromolecular binding of N-[4-(5-nitro-2-furyl)-2-thiazolyl]- formamide in germfree versus conventional rats.
Morton KC; Wang CY
Cancer Res; 1983 Aug; 43(8):3628-32. PubMed ID: 6190554
[TBL] [Abstract][Full Text] [Related]
58. Effect of aspirin on N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced epithelial proliferation in the urinary bladder and forestomach of the rat.
Hasegawa R; St John M; Murasaki G; Fukushima S; Cohen SM
Cancer Lett; 1984 Jan; 21(3):269-75. PubMed ID: 6692345
[TBL] [Abstract][Full Text] [Related]
59. Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced bladder carcinogenesis and enhancement of forestomach carcinogenesis.
Murasaki G; Zenser TV; Davis BB; Cohen SM
Carcinogenesis; 1984 Jan; 5(1):53-5. PubMed ID: 6690086
[TBL] [Abstract][Full Text] [Related]
60. Enhancement by phenothiazine and 2,5-di-O-acetyl-D-glucosaccharo-(1,4)(6,3)-dilactone of bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in rats.
Wang CY; Hayashida S
Cancer Lett; 1984 Aug; 24(1):37-43. PubMed ID: 6548659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
